The following discussion and analysis of our Company's financial condition and
results of operations should be read in conjunction with our unaudited condensed
consolidated financial statements and the related notes included elsewhere in
the report. This discussion contains forward-looking statements that involve
risks and uncertainties. Actual results and the timing of selected events could
differ materially from those anticipated in these forward-looking statements as
a result of various factors. See "Cautionary Note Concerning Forward-Looking
Statements" on page 2.



The description of our business included in this quarterly report is summary in
nature and only includes material developments that have occurred since the
latest full description. The full discussion of the history and general
development of our business is included in "Item 1. Description of Business"
section of the Company's Annual Report on Form 10-K filed with the SEC April 15,
2022,, which section is incorporated by reference.



Unless otherwise noted, all currency figures quoted as "U.S. dollars", "dollars"
or "US$" refer to the legal currency of the United States. References to
"Chinese Yuan" or "Renminbi ("RMB")" are to the Chinese Yuan, the legal currency
of the People's Republic of China. Throughout this report, assets and
liabilities of the Company's subsidiaries are translated into U.S. dollars using
the exchange rate on the balance sheet date. Revenue and expenses are translated
at average rates prevailing during the period. The gains and losses resulting
from translation of financial statements of foreign subsidiaries are recorded as
a separate component of accumulated other comprehensive income within the
statement of stockholders' equity.



We were incorporated under the laws of the State of Nevada on June 15, 2006, as
Jupiter Resources, Inc. Our name was changed to Rineon Group, Inc. on April 30,
2009, and AS Capital, Inc. on October 1, 2018. On August 6, 2021, we consummated
a share exchange transaction with the shareholders of HanJiao International
Holding Limited, its subsidiaries and variable interest entity, Beijing Yingjun
Technology Co., Ltd., or "Beijing VIE". As a result of the share exchange
transaction, we entered into the business of providing health and wellness
related products through our e-commerce platform to the middle-aged and elderly
populations in the People's Republic of China ("China" or the "PRC") which
business is conducted through Beijing VIE. On October 20, 2021, we changed our
name to Hanjiao Group, Inc. The shares of our common stock are currently quoted
under the symbol "HJGP."



Beijing VIE, a variable interest entity that we control through contractual
arrangements, was formed in Beijing, China, on March 27, 2007. Initially,
Beijing VIE focused on the provision of services in paper media, publication of
magazines and books, and investment in media businesses. Due to the downturn of
the paper media industry and the rise of the elderly healthcare services
industry, in 2013, Beijing VIE shifted its business focus to the provision of
healthcare related products through its e-commerce platform to the middle-aged
and elderly segments in the PRC.



In 2016, Beijing VIE expanded its e-commerce operations and introduced its
"Fozgo" branded products via its online to offline (O2O) marketplace. The O2O
platform integrates its e-commerce platform with physical outlets to connect
consumers and merchants in a dynamic marketplace. Its platform not only offers
users the convenience of making online purchases, but also provides users the
possibility to purchase and receive products at offline service centers.
Currently, Beijing VIE's core product categories include nutritional
supplements, cosmetics, smart home products (such as smart watches) and home
appliances (such as water filters and air purifiers). Beijing VIE has developed
several branch offices with outlets across the PRC with approximately 163,000
users. In 2018 and 2022, Beijing VIE was granted hi-tech enterprise status in
the PRC and in 2022, it was identified as Zhongguancun High-tech Enterprise

in
Beijing.


Beijing VIE owns a 44% equity interest in Rongcheng Tianrun Taxus Co., Ltd. ("Rongcheng Tianrun"), a PRC company. Rongcheng Tianrun is engaged primarily in the cultivation and marketing of Taxus, a type of medicinal plant.











  38






Our principal executive offices are located at Room 119, No.778 Tanghekou
Street, Tanghekou Town, Huairou District, Beijing and our telephone number is
+86-10-63622901. At present, enterprises in Huairou District can enjoy the best
tax preferential policies in Beijing. We maintain an Internet website at
www.hanjiaoguoji.com. The information contained in, or accessible from, our
website is not a part of this Quarterly Report.



Impact of COVID-19 on our business.


Our business has been significantly and adversely affected by the COVID-19
pandemic and the resulting governmental containment measures such as
quarantines, travel restrictions, and the temporary closure of stores and
business facilities in China. China continues to be affected by the COVID-19
pandemic and its ongoing containment measures. Because substantially all of the
Company's business operations and its workforce are concentrated in China, the
Company's business, results of operations, and financial condition have been
adversely affected. For the nine months ended September 30, 2022, the Company
had a net loss of approximately $4 million. At September 30, 2022, the Company
has a significant working capital deficiency of approximately $33.3 million, and
a shareholders' deficit of approximately $15.0 million. These conditions raise
substantial doubt about the Company's ability to continue as a going concern.



To mitigate the overall financial impact of COVID-19 on the Company's business,
management introduced cost containment and staff reduction measures, revised
product selection and incentive programs and worked with its service centers
continuously to enhance their marketing and promotion activities. Management
believes that COVID-19 will continue to have a material impact on its financial
results for the remainder of 2022 and the first half of 2023, which could cause
the potential impairment of certain assets. Accordingly, we expect to continue
implementing cost containment measures, work closely with our service centers
with offline, online and virtual marketing and promotion activities, as well as
actively recruit key sales members and obtain product and service
collaborations. While the main shareholder of the Company has pledged to give
financial support for the Company's operations in China, there can be no
assurance that this support will be sufficient to enable the Company to continue
as a going concern.



Results of Operations.



Our unaudited condensed consolidated financial statements have been prepared on
a going concern basis, which assumes that we will be able to continue to operate
in the future in the normal course of business. Our unaudited condensed
consolidated financial statements for the nine months ended September 30, 2022,
includes a note about our ability to continue as a going concern due to losses
from operations in 2022 and through the quarter ended September 30, 2022 as a
result of COVID-19. Business closures in the PRC and limitations on business
operations arising from COVID-19 has significantly disrupted our ability to
generate revenues and cash flow during the nine months ended September 30, 2022.



While the Company cannot accurately predict the full impact of COVID-19 on its
business in 2022, management believes that its business will gradually stabilize
in 2022 as market conditions in China continue to improve. In assessing the
Company's liquidity, management monitors and analyzes its cash on hand and its
operating expenses, and existing regulatory obligations and commercial
commitments. The Company can sell the apartment in Beijing if they have cash
issues. The major shareholder of the Company pledged to give financial support
to continue the Company's operations. In assessing the Company's liquidity,
management monitors and analyzes its cash on hand and its operating expenses,
and existing regulatory obligations and commercial commitments.









  39





Comparison for the Three Months Ended September 30, 2022 and 2021

The following table sets forth certain financial data for the three months ended September 30, 2022 and 2021:





                                     For the Three Months Ended September 30,             Percentage
                                       2022                            2021                 Change
                             Dollars                          Dollars
                           (Unaudited)           %          (Unaudited)          %             %
Revenues                   $      8,213           100.0     $  1,052,323          100.0         (99.2 )
Cost of revenues                 (2,372 )         (28.9 )       (645,030 )        (61.3 )        99.6
Reversal of inventory
allowance                        10,075           122.7          138,812           13.2          92.7
Gross profit                     15,916           193.8          546,105           51.9         (97.1 )

General and
administrative expenses         288,082         3,507.6          618,099           58.7         (53.4 )
Selling expenses                 82,487         1,004.4          452,822           43.0         (81.8 )
Finance expenses, net             4,430            53.9           10,957            1.0         (59.6 )
Total operating expenses        374,999         4,565.9        1,081,878          102.7         (65.3 )

Operating loss                 (359,083 )      (4,372.1 )       (535,773 )        (50.8 )       (33.0 )

Other expenses, net            (757,869 )      (9,227.7 )       (801,002 )        (76.1 )        (5.4 )
Loss from equity
investment                      (26,512 )        (322.8 )              -                            -

Total other expenses,
net                            (784,381 )      (9,550.5 )       (801,002 )        (76.1 )        (2.1 )
Loss before provision

for income taxes             (1,143,464 )     (13,922.6 )     (1,336,775 )       (126.9 )       (14.5 )
Provision for income
taxes                                 -               -                -              -             -

Net loss                   $ (1,143,464 )     (13,922.6 )   $ (1,336,775 )       (126.9 )       (14.5 )

Foreign currency
translation adjustment          791,017         9,631.3          (17,027 )         (1.6 )    (4,745.7 )

Comprehensive loss         $   (352,447 )      (4,291.3 )   $ (1,353,802 )       (128.5 )       (74.0 )




Revenues. Revenues decreased 99.2% or approximately $1 million to $8,000 from
approximately $1.1 million for the three months ended September 30, 2021 was
primarily due to COVID-19 outbreak during the third quarter in 2022. During the
three months ended September 30, 2022 and 2021, all revenues were generated in
the PRC; and no customers accounted for 10% or more of total revenues. During
the three months ended September 30, 2022 and 2022, revenues were mainly from
sales of health foods.



Cost of revenues. Cost of revenues consists primarily of the cost of merchandise
sold, delivery cost, service fees, sales incentives and commissions that are
directly attributable to the sale of certain designated products. Cost of
revenues of approximately $2,372 for the three months ended September 30, 2022
and $645,030 for the three months ended September 30, 2021. The decrease in cost
of revenues of approximately $642,658 or 99.6% from the comparable period of
2021 was due mainly to sales growth concentrated in first-quarter rather than
second-quarter of 2022.







  40





There were no suppliers that accounted for more than 10% of total purchases for the three months ended September 30, 2022.





Gross profit (Loss): Gross profit was approximately $16,000 and $546,000 for the
three months ended September 30, 2022 and 2021, respectively. The decrease in
gross profit of approximately $532,000 or 97.1% from the comparable period of
2021 was due mainly to the decrease in product sales as a result of outbreak of
COVID-19 in 2022.



General and Administrative Expenses. General and administrative expenses ("G&A
expenses") consist primarily of salary and benefits for our general
administrative and management staff, facilities costs, depreciation expenses,
professional and audit fees, and other miscellaneous expenses incurred in
connection with general operations. G&A expenses decreased 53.4% or
approximately $330,000 to $288,000 from approximately $618,000 for the three
months ended September 30, 2021 was due primarily to the decrease in advisory
fees, salaries and benefits.



Selling Expenses. Selling expenses consist mainly of payroll and benefits for
employees involved in the sales and distribution functions, meeting/event fees,
advertisement, and marketing and selling expenses that are related to events and
activities at the Company's service centers designed to promote product sales.
Selling expenses decreased by 81.8% or approximately $370,000 to approximately
$82,000 in the three months ended September 30, 2022 from approximately $453,000
in the same period of 2021. The decrease was due mainly to the Company's cost
containment plan and initiatives to scale back its marketing expenses in 2022 as
the PRC economy continues to recover from the COVID pandemic. During the same
period of 2021, the Company organized numerous events designed to boost product
sales in light of the negative impact of COVID-19 on its business.



Finance Expenses, net. Finance expenses consist mainly of service fees related
to the use of third-party online payment platforms, bank fees and interest
expenses related to borrowings; net of interest income from bank and related
bank products. Total net financial expenses were approximately $4,000 and
$11,000 for the three months ended September 30, 2022, and 2021, respectively.
The decrease in net financial expenses was due mainly to decrease in interest
expenses in the three months ended September 30, 2022.



Operating Loss. Compared to the same period of 2021, operating loss decreased by
approximately $177,000 for the three months ended September 30, 2022. The
decrease in operating loss in 2022 was due primary to the decrease of the sales
due to outbreak of the COVID-19.



Total Other Expenses, net. Other expenses consist mainly of estimated tax
penalties. Total net other expenses were approximately $784,000 for the three
months ended September 30, 2022, compared to approximately $801,000 for the same
period of 2021. The decrease in total net other expenses was due primary to
decrease in estimated tax penalty in 2022.



Provision for Income Taxes. No provision for income taxes was recorded for the
three months ended September 30, 2022 and 2021 since the Company reported a
pre-tax loss of approximately $1.1 million and $1.3 million for the three months
ended September 30, 2022 and 2021.



Net Loss. As a result of the factors described above, net loss was approximately
$1.1 million for the three months ended September 30, 2022, a decrease of
approximately $193,000 from approximately $1.3 million of net loss for the

same
period of 2021.


Comprehensive Loss.Factoring in the impact of foreign currency translation adjustment, comprehensive loss was approximately $352,000 and $1.4 million for the three months ended September 30, 2022 and 2021, respectively.











  41





Comparison for the nine months Ended September 30, 2022 and 2021

The following table sets forth certain financial data for the nine months ended September 30, 2022 and 2021





                                     For the Nine months Ended September 30,               Percentage
                                      2022                            2021                   Change
                             Dollars            %            Dollars            %               %
Revenues                   $    775,617          100.0     $  1,630,559          100.0           (52.4 )
Cost of revenues               (371,128 )        (47.8 )     (1,085,464 )        (66.6 )          65.8
Provision for inventory
allowance                       (59,103 )         (7.7 )        (71,836 )         (4.4 )          17.7
Gross profit                    345,386           44.5          473,259           29.0           (27.0 )

General and

administrative expenses       1,325,547          170.6        1,931,899          118.5           (31.5 )
Selling expenses                672,247           86.7        1,481,633           90.9           (54.6 )
Finance expenses, net            15,987            2.1           28,132            1.7           (43.2 )
Total operating expenses      2,011,781          259.4        3,441,664    

     211.1           (41.5 )

Operating loss               (1,666,395 )       (214.9 )     (2,968,405 )       (182.1 )         (43.9 )

Other expenses, net          (2,354,583 )       (303.6 )     (2,348,908 )       (144.1 )           0.2
Loss from equity
investment                      (33,306 )         (4.3 )         (8,166 )         (0.5 )         307.9


Total other expenses,
net                          (2,387,889 )       (307.9 )     (2,357,074 )       (144.6 )           1.3
Loss before provision
for income taxes             (4,054,284 )       (522.8 )     (5,325,479 )       (326.7 )         (23.9 )
Provision for income
taxes                                 -              -                -              -               -
Net loss                     (4,054,284 )       (522.8 )     (5,325,479 )       (326.7 )         (23.9 )

Foreign currency

translation adjustment        1,507,114          194.3          (33,119 )  

(2.0 ) (4,650.6 )



Comprehensive loss         $ (2,547,170 )       (328.5 )   $ (5,358,598 )       (328.7 )         (52.5 )




Revenues: Revenues were approximately $776,000 and approximately $1.6 million
for the nine months ended September 30, 2022 and 2021 respectively. The decrease
in revenues of approximately $855,000 or 52.4% is due primarily to outbreak of
the COVID-19 in 2022. During the nine months ended September 30, 2022 and 2021,
all revenues were generated in the PRC. During the nine months ended September
30, 2022, revenues were mainly attributable to the sales of health foods and
cold Gel, representing 56.7%, and 17.9% of revenues, respectively. For the
period of nine months ended September 31, 2021 and 2020, revenues were mainly
attributable to the sales of health foods, smart watches and cosmetics products.
During the nine months ended September 30, 2022 and 2021, no customers accounted
for 10% or more of total revenues.



Cost of revenues:Cost of revenues consists primarily of the cost of merchandise
sold, delivery cost, service fees, sales incentives and commissions that are
directly attributable to the sale of certain designated products. Cost of
revenues of approximately $371,000 for the nine months ended September 30, 2022
and $1.1 million for the nine months ended September 30, 2021. The decrease in
cost of revenues of approximately $714,000 or 65.8% from the comparable period
of 2022 was due mainly to decrease in product sales as a result of COVID-19
outbreak in 2022.



There were two suppliers that accounted for more than 10% of total purchases,
for the nine months ended September 30, 2022. One supplier (Baoqing Meilai
Modern Agricultural Service Co., Ltd.) accounted for 86% for the nine months
ended September 30, 2022. The other supplier (One Four One Three (Tianjin)
Network Technology Development Co., Ltd.) accounted for 14% for the nine months
ended September 30, 2022.









  42






Gross Profit. Gross profit was approximately $345,000 and $473,000 for the nine
months ended September 30, 2022 and 2021. The decrease in gross profit of
approximately $128,000 or 27% from the comparable period of 2021 was due mainly
to the decrease in product sales as a result of outbreak of COVID-19 in 2022.



General and Administrative Expenses. General and administrative expenses ("G&A
expenses") consist primarily of costs in salary and benefits for our general
administrative and management staff, facilities costs, depreciation expenses,
professional fees, audit fees, and other miscellaneous expenses incurred in
connection with general operations. G&A expenses decreased 31.5% or
approximately $608,000 to approximately $1.3 million in the nine months ended
September 30, 2022 from approximately $1.9 million for the nine months ended
September 30, 2021 was due primarily to the decrease in advisory fees, salary
and benefits.



Selling Expenses. Selling expenses consist mainly of payroll and benefits for
employees involved in the sales and distribution functions, meeting/event fees,
advertisement, and marketing and selling expenses that are related to events and
activities at the Company's service centers designed to promote product sales.
Selling expenses decreased by 54.6% or approximately $809,000 to approximately
$672,000 in the nine months ended September 30, 2022 from approximately $1.5
million in the same period of 2021. The decrease was due mainly to fewer events
and lower travel expenses because of the negative impact of COVID-19.



Finance Income, net. Total net financial expense was approximately $16,000 for
the nine months ended September 30, 2022, compared to approximately $28,000 for
the same period of 2021. The decrease was due mainly to lower interest earned
from bank and related bank products in the nine months period ended September
30, 2021.



Operating LossOperating loss was approximately $1.7 million for the nine months
ended September 30, 2022, compared to approximately $3 million for the same
period of 2021. The decrease in operating loss in 2021 was due primary to the
decrease of operating expenses.



Total Other Expenses, net. Other expenses consist mainly of estimated tax
penalties. Total net other expenses were approximately $2.4 million for the nine
months ended September 30, 2022, compared to approximately $2.4 million for

the
same period of 2021.



Provision for Income Taxes. No provision for income taxes was recorded for the
nine months ended September 30, 2022 and 2021 since the Company reported a
pre-tax loss of approximately $4.1 million and $5.3 million for the nine months
ended September 30, 2022 and 2021.



Net Loss. As a result of the factors described above, net loss was approximately
$4.1 million for the nine months ended September 30, 2022, a decrease of
approximately $1.2 million from approximately $5.3 million of net loss for

the
same period of 2022.


Comprehensive LossComprehensive loss was approximately $2.4 million and $5.4 million for the nine months ended September 30, 2022 and 2021.

Liquidity and Capital Resources

As of September 30, 2022 and December 31, 2021, we had cash and cash equivalents of approximately $5,000 and $839,000, respectively.





The following table sets forth a summary of our cash flows for the periods as
indicated:



                                                         For the Nine Months Ended
                                                               September 30,
                                                           2022              2021
                                                        (Unaudited)      (Unaudited)

Net cash used in provided by operating activities $ (760,703 ) $ (2,159,012 ) Net cash used in investing activities

                              -         (196,680 )
Effect of exchange rate changes on cash and cash
equivalents                                                  (73,355 )     

12,869


Net (decrease) in cash and cash equivalents                 (834,058 )     (2,342,823 )
Cash and cash equivalents at beginning of period             838,850       

3,257,005


Cash and cash equivalents at end of period             $       4,792     $ 

  914,182












  43





The following table sets forth a summary of our working capital:





                            September 30,      December 31,
                                 2022              2021           Variation          %
                             (Unaudited)
Total Current Assets        $      229,556     $   1,319,947     $ (1,090,391 )     (82.6 )
Total Current Liabilities       33,744,658        34,453,169         (895,840 )      (2.6 )
Working Capital (Deficit)   $  (33,515,102 )   $ (33,133,222 )   $   (194,551 )       0.6



Working Capital. The deterioration in the Company's working capital was due mainly to continuing net losses generated as a result of COVID-19.





Cash used in operating activities was approximately $761,000 and $2.2 million
for nine months ended September 30, 2022 and 2021, respectively. The key factors
attributing to the net cash outflows in 2022 include: net loss of approximately
$4.1 million, increase in inventory of approximately $242,000, and other
payables and other current liabilities of approximately $3.2 million and offset
by the decrease in advance from customers of approximately $302,000.



For the nine months ended September 30, 2021, cash used in operating activities
was approximately $2.2 million was due primary to decrease in net loss of
approximately $6.1 million, and increase in net cash inflow from changes in
advances to suppliers of approximately $186,000; inventories of approximately
$297,000; other payables and other current liabilities of approximately $2.5
million, partially offset by the decrease in tax payable of approximately
$208,000.



Net cash used in investing activities was approximately nil and $197,000 for the
nine months ended September 30, 2022 and 2021, respectively. Net cash used in
investing activities of approximately $197,000 for the nine months ended
September 30, 2021 was related to the purchases of property and equipment.



The Company expect to continue implementing cost containment measures, work
closely with our service centers with offline, online and virtual marketing and
promotion activities, as well as actively recruit key sales members and obtain
product and service collaborations. The shareholder of the Company pledge to
give financial support for the Company operation.



Off-Balance Sheet Arrangements





We have not entered into any financial guarantees or other commitments to
guarantee the payment obligations of any third parties. In addition, we have not
entered into any derivative contracts that are indexed to our own shares and
classified as shareholders' equity, or that are not reflected in our financial
statements. Furthermore, we do not have any retained or contingent interest in
assets transferred to an unconsolidated entity that serves as credit, liquidity
or market risk support to such entity. Moreover, we do not have any variable
interest in an unconsolidated entity that provides financing, liquidity, market
risk or credit support to us or engages in leasing, hedging or research and

development services with us.



Critical Accounting Policies



We prepare our financial statements in conformity with accounting principles
generally accepted by the United States of America ("U.S. GAAP"), which require
us to make judgments, estimates, and assumptions that affect our reported amount
of assets, liabilities, revenue, costs and expenses, and any related
disclosures. Although there were no material changes made to the accounting
estimates and assumptions in the past three years, we continually evaluate these
estimates and assumptions based on the most recently available information, our
own historical experience and various other assumptions that we believe to be
reasonable under the circumstances. Since the use of estimates is an integral
component of the financial reporting process, actual results could differ from
our expectations as a result of changes in our estimates.



We believe that our accounting policies involve a higher degree of judgment and
complexity in their application and require us to make significant accounting
estimates. Accordingly, the policies we believe are the most critical to
understanding and evaluating our consolidated financial condition and results of
operations are summarized in "Note 3 - Summary of Significant Accounting
Policies" in the notes to our unaudited condensed consolidated financial
statements.









  44





Recent Accounting Pronouncements





See "Note 3 - Summary of Significant Accounting Policies" in the notes to our
unaudited condensed consolidated financial statements for a discussion of recent
accounting pronouncements.



The Company believes that other recent accounting pronouncement will not have a
material effect on the Company's consolidated financial position, results of
operations and cash flows.

© Edgar Online, source Glimpses